Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Xetra  >  Medios AG    ILM1   DE000A1MMCC8

MEDIOS AG

(ILM1)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Xetra
01/19/2021 01/20/2021 01/21/2021 01/22/2021 01/25/2021 Date
39.2(c) 40(c) 40(c) 39(c) 38.4 Last
8 579 20 898 8 009 5 700 1 222 Volume
+3.70% +2.04% 0.00% -2.50% -1.54% Change
More quotes
Financials
Sales 2020 620 M 754 M 754 M
Net income 2020 8,00 M 9,72 M 9,72 M
Net cash position 2020 57,8 M 70,2 M 70,2 M
P/E ratio 2020 91,4x
Yield 2020 -
Sales 2021 1 219 M 1 481 M 1 481 M
Net income 2021 22,2 M 27,0 M 27,0 M
Net cash position 2021 24,9 M 30,3 M 30,3 M
P/E ratio 2021 35,0x
Yield 2021 -
Capitalization 627 M 764 M 762 M
EV / Sales 2020 0,92x
EV / Sales 2021 0,49x
Nbr of Employees 276
Free-Float 89,6%
More Financials
Company
Medios AG, formerly Crevalis Capital AG, is a Germany-based company that is active in the pharmacy business. It wholesales, markets, distributes and produces various kinds of goods for pharmacies and other pharmaceutical companies. The Company also provides related services and is engaged in the acquisition and management of other companies from the pharmaceutical industry. 
Sector
Drug Retailers
Calendar
-
More about the company
Notations Surperformance© of Medios AG
Trading Rating : Investor Rating :
More Ratings
All news about MEDIOS AG
01/22MEDIOS AG : Release according to Article 40, Section 1 of the WpHG [the German S..
EQ
01/21MEDIOS AG : Release according to Article 41 of the WpHG [the German Securities T..
EQ
01/21PRESS RELEASE : Medios AG: Successful completion of the Cranach Pharma acquisiti..
DJ
01/21MEDIOS AG : Successful completion of the Cranach Pharma acquisition - Market pos..
EQ
2020PRESS RELEASE : Medios AG: Planned takeover of Cranach Pharma GmbH approved by C..
DJ
2020MEDIOS AG : Planned takeover of Cranach Pharma GmbH approved by Cartel Office
EQ
2020MEDIOS : Warburg Research remains its Buy rating
MD
2020MEDIOS : Berenberg reaffirms its Buy rating
MD
2020MEDIOS : Receives a Buy rating from Kepler Cheuvreux
MD
2020DGAP-AFR : Medios AG: Preliminary announcement of the publication of financial r..
DJ
2020MEDIOS : Kepler Cheuvreux gives a Buy rating
MD
2020MEDIOS : Jefferies reaffirms its Buy rating
MD
2020MEDIOS : Gets a Buy rating from Warburg Research
MD
2020MEDIOS AG : Sales increase to more than ?1 billion through acquisition of Cranac..
EQ
2020PRESS RELEASE : Medios AG: Sales increase to more than ?1 billion through acquis..
DJ
More news
News in other languages on MEDIOS AG
01/22DGAP-PVR : Medios AG: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der e..
01/21DGAP-NVR : Medios AG: Veröffentlichung der Gesamtzahl der Stimmrechte nach § 41 ..
01/21DGAP-NEWS : Medios AG: Erfolgreicher Abschluss der Akquisition von Cranach Pharm..
01/21MEDIOS AG : Erfolgreicher Abschluss der Akquisition von Cranach Pharma - Deutlic..
2020MEDIOS AG : Kartellfreigabe für die geplante Übernahme der Cranach Pharma GmbH
More news
Analyst Recommendations on MEDIOS AG
More recommendations
Stock Trading Strategies
MEDIOS AG - 2020
Back on key levels based on weekly price data
BUY
More Stock Trading Analysis
Chart MEDIOS AG
Duration : Period :
Medios AG Technical Analysis Chart | ILM1 | DE000A1MMCC8 | MarketScreener
Technical analysis trends MEDIOS AG
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 3
Average target price 47,00 €
Last Close Price 39,00 €
Spread / Highest target 28,2%
Spread / Average Target 20,5%
Spread / Lowest Target 7,69%
EPS Revisions
Managers and Directors
NameTitle
Matthias A. Gärtner Chief Executive Officer
Yann Samson Chairman-Supervisory Board
Mi Young Miehler Chief Operating Officer
Klaus Buß Member-Supervisory Board
Joachim Messner Vice Chairman-Supervisory Board
Sector and Competitors